IMPORTANCE: The patients evaluated in this study, to our knowledge, represent the first complete clinical description of a family with an autosomal dominant inheritance pattern of retinal dystrophy associated with a novel mutation in RAX2. OBJECTIVES: To clinically evaluate 4 patients and 5 unaffected family members, characterize the disease phenotype over time, and identify the associated genetic mutation. DESIGN, SETTING, AND PARTICIPANTS: A prospective, longitudinal, observational, case-series analysis of 9 members of an affected family at the Casey Eye Institute, Oregon Health and Science University, Portland. The dates of the study were from July 31, 1992, to August 11, 2014. INTERVENTIONS: Clinical evaluations included eye examination, color fundus photography, autofluorescence imaging, spectral-domain optical coherence tomography, kinetic visual field testing, and electroretinography. Genetic mutation screening was performed with next-generation sequencing, and identified mutations were confirmed with Sanger sequencing. MAIN OUTCOMES AND MEASURES: Clinical diagnosis and longitudinal characterization of retinal dystrophy and identification of genetic mutation. RESULTS: Six members of the family were identified as having retinal dystrophy (4 were examined, and 3 were genetically tested). Five unaffected family members were clinically evaluated (2 were genetically tested). The age at onset of retinal dystrophy was variable. All affected individuals presented with declining visual acuity, central scotomas, waxy disc pallor, attenuated vasculature, small yellow macular deposits and/or macular pigment mottling, and abnormal electroretinograms demonstrating mixed cone and rod dysfunction and a scotopic electronegative response to bright flashes. There were no other causes of an electronegative electroretinogram identified in any of the affected patients. Genetic testing revealed, to our knowledge, a novel frameshift heterozygous mutation in RAX2 in the patients with retinal dystrophy. CONCLUSIONS AND RELEVANCE: A frameshift heterozygous mutation in RAX2 inherited in an autosomal dominant fashion was associated with mixed cone and rod dysfunction. Among the patients, there was variability in the age at onset and in the specific pattern of photoreceptor dysfunction, but the clinical course was nevertheless slowly progressive. Screening for RAX2 mutation could provide prognostic value for patients and families with scotopic electronegative responses to bright flashes.
IMPORTANCE: The patients evaluated in this study, to our knowledge, represent the first complete clinical description of a family with an autosomal dominant inheritance pattern of retinal dystrophy associated with a novel mutation in RAX2. OBJECTIVES: To clinically evaluate 4 patients and 5 unaffected family members, characterize the disease phenotype over time, and identify the associated genetic mutation. DESIGN, SETTING, AND PARTICIPANTS: A prospective, longitudinal, observational, case-series analysis of 9 members of an affected family at the Casey Eye Institute, Oregon Health and Science University, Portland. The dates of the study were from July 31, 1992, to August 11, 2014. INTERVENTIONS: Clinical evaluations included eye examination, color fundus photography, autofluorescence imaging, spectral-domain optical coherence tomography, kinetic visual field testing, and electroretinography. Genetic mutation screening was performed with next-generation sequencing, and identified mutations were confirmed with Sanger sequencing. MAIN OUTCOMES AND MEASURES: Clinical diagnosis and longitudinal characterization of retinal dystrophy and identification of genetic mutation. RESULTS: Six members of the family were identified as having retinal dystrophy (4 were examined, and 3 were genetically tested). Five unaffected family members were clinically evaluated (2 were genetically tested). The age at onset of retinal dystrophy was variable. All affected individuals presented with declining visual acuity, central scotomas, waxy disc pallor, attenuated vasculature, small yellow macular deposits and/or macular pigment mottling, and abnormal electroretinograms demonstrating mixed cone and rod dysfunction and a scotopic electronegative response to bright flashes. There were no other causes of an electronegative electroretinogram identified in any of the affected patients. Genetic testing revealed, to our knowledge, a novel frameshift heterozygous mutation in RAX2 in the patients with retinal dystrophy. CONCLUSIONS AND RELEVANCE: A frameshift heterozygous mutation in RAX2 inherited in an autosomal dominant fashion was associated with mixed cone and rod dysfunction. Among the patients, there was variability in the age at onset and in the specific pattern of photoreceptor dysfunction, but the clinical course was nevertheless slowly progressive. Screening for RAX2 mutation could provide prognostic value for patients and families with scotopic electronegative responses to bright flashes.
Authors: Erik S Davis; Gareth Voss; Joel B Miesfeld; Juan Zarate-Sanchez; S Randal Voss; Tom Glaser Journal: Dev Dyn Date: 2020-09-17 Impact factor: 3.780
Authors: Stijn Van de Sompele; Claire Smith; Marianthi Karali; Marta Corton; Kristof Van Schil; Frank Peelman; Timothy Cherry; Toon Rosseel; Hannah Verdin; Julien Derolez; Thalia Van Laethem; Kamron N Khan; Martin McKibbin; Carmel Toomes; Manir Ali; Annalaura Torella; Francesco Testa; Belen Jimenez; Francesca Simonelli; Julie De Zaeytijd; Jenneke Van den Ende; Bart P Leroy; Frauke Coppieters; Carmen Ayuso; Chris F Inglehearn; Sandro Banfi; Elfride De Baere Journal: Genet Med Date: 2018-10-31 Impact factor: 8.822